European drug discovery and development: success stories
Drug Discovery World
OCTOBER 6, 2022
until 2030. In Germany the development of the Covid-19 vaccine, largely due to the achievements of BioNTech, raised the country’s biotech profile. Lang notes: “The opportunities extend beyond coronavirus vaccines. Lu Rahman highlights some of the key players. . The European drug discovery sector is buoyant. Valued at $14.8
130 
Let's personalize your content